argenx SE reported $59.8M in Ordinary Share Capital for its fiscal quarter ending in June of 2024.





Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 73K Mar/2026
Genmab DKK 61.62M 52K Dec/2025
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
GRIFOLS EUR 680.58M 0 Mar/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lakefront Biotherapeutics EUR 65.9M 0 Mar/2026
Qiagen NV USD 216.56M 284.67K Dec/2025
UCB EUR 190.36M 365.15K Dec/2025